The Story of Serratia Marcescens: Pathologic Risk Factors in Breast Implant Surgery

Serratia marcescens (S. marcescens) emerged as an opportunist in the setting of immunodeficiency in the 1970s, when serious infections occurred in San Francisco hospitals after USA. Navy experiments had aerosolized the bacteria to study biologic warfare. We investigate the risks of S. marcescens in San Franciscans who undergo mastectomy with implant reconstruction. From 2007 to 2011, the senior author took breast capsule cultures for all patients at the time of tissue expander exchange/explant. Of the 142 women who had reconstruction, 23 had positive cultures. Only the two patients who were positive for S. marcescens developed clinical infections that required explantation. Both had postoperative chemotherapy with transient neutropenia, and both had close ties to San Francisco. Clinical signs of infection emerged for both patients months after initial surgery, despite having previously well healed incisions. Other patients were culture positive for Pseudomonas, Proteus, Enterococcus and MRSA and did not develop require explant. While the link between San Francisco and S. marcescens is controversial, a patient's geography is a simple screening tool when considering postoperative risks, especially in the immunocompromised. Closer monitoring for neutropenia during chemotherapy, and a lower threshold to administer S. marcescens targeted antibiotics may be warranted in these patients.

Keywords

Breast implant - Serratia - Device removal - Infection - San francisco

This article was presented at The American College of Surgeons (Southern California Chapter) Annual Scientific Meeting: The Story of Serratia Marcescens: Pathologic Risk Factors in Breast Implant Surgery on January 20, 2012 in Santa Barbara, CA, USA.

Publication History

Received: 14 September 2013

Accepted: 28 May 2014

Article published online:
05 May 2022

• References

• 1 Yu VL. Serratia marcescens: historical perspective and clinical review. N Engl J Med 1979; 300: 887-893
• 2 United States. Congress. Senate. Committee on Human Resources. Subcommittee on Health Scientific Research. Biological Testing Involving Human Subjects by the Department of Defense, 1977: Hearings Before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, United States Senate, Ninety-fifth Congress, First Session ... March 8 and May 23, 1977. US Government Printing Office; 1977
• 3 US Department of the Army. US Army Activity in the US Biological Warfare Programs: Vol. II. Annexes. Washington DUDoAPDB;
• 4 Wheat RP, Zuckerman A, Rantz LA. Infection due to chromobacteria; report of 11 cases. AMA Arch Intern Med 1951; 88: 461-466
• 5 Fishbach RS, Rosenblatt JE, Dahlgren JG. Pyogenic vertebral osteomyelitis in heroin addicts. Calif Med 1973; 119: 1-4
• 6 Mills J, Drew D. Serratia marcescens endocarditis: a regional illness associated with intravenous drug abuse. Ann Intern Med 1976; 84: 29-35
• 7 Mahlen SD. Serratia infections: from military experiments to current practice. Clin Microbiol Rev 2011; 24: 755-791
• 8 Chen NT, Butler PE, Hooper DC. et al. Bacterial growth in saline implants: in vitro and in vivo studies. Ann Plast Surg 1996; 36: 337-341
• 9 McCarthy CM, Mehrara BJ, Riedel E. et al. Predicting complications following expander/implant breast reconstruction: an outcomes analysis based on preoperative clinical risk. Plast Reconstr Surg 2008; 121: 1886-1892
• 10 Leyngold MM, Stutman RL, Khiabani KT. et al. Contributing variables to post mastectomy tissue expander infection. Breast J 2012; 18: 351-356